The risk is clearly on the downside. If the drug is rejected initially - the price falls to twenty cents. If the drug is accepted, the market then starts to focus on the low probability that biotechs face in actually making money from a drug.
I think the current price is a good risk / reward to SELL.
- Forums
- ASX - By Stock
- CXS
- 2 weeks to go...
2 weeks to go..., page-13
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online